Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2451
Biohaven
BHVN
$1.93B
| $3.62M | ﹤0.01% |
320,846
-25,998
| -7% | -$322K |
2022 Q4
12 quarters
|
|
|
CALY
2452
Callaway Golf Company
CALY
$2.52B
| $3.62M | ﹤0.01% |
310,242
+16,021
| +5% | +$169K |
2016 Q1
39 quarters
|
|
2453
Precigen
PGEN
$3B
| $3.62M | ﹤0.01% |
865,378
+309,522
| +56% | +$1.2M |
2022 Q1
15 quarters
|
|
2454
PUT
Hewlett Packard
HPE
$89.8B
| $3.6M | ﹤0.01% |
150,000
-50,000
| -25% | -$1.18M |
2025 Q3
1 quarter
|
|
2455
WEX
WEX
$5.83B
| $3.59M | ﹤0.01% |
24,104
-42,815
| -64% | -$6.45M |
2013 Q2
50 quarters
|
|
|
CON
2456
Concentra Group Holdings
CON
$4.57B
| $3.59M | ﹤0.01% |
182,318
+15,661
| +9% | +$313K |
2024 Q3
5 quarters
|
|
2457
Aurora
AUR
$11.3B
| $3.59M | ﹤0.01% |
933,720
-38,427
| -4% | -$176K |
2022 Q1
15 quarters
|
|
2458
Immunocore
IMCR
$1.54B
| $3.58M | ﹤0.01% |
103,253
-3,790
| -4% | -$134K |
2022 Q1
15 quarters
|
|
2459
Teekay Tankers
TNK
$3.61B
| $3.58M | ﹤0.01% |
66,975
-319
| -0.5% | -$17.9K |
2022 Q1
15 quarters
|
|
2460
Kemper
KMPR
$1.5B
| $3.58M | ﹤0.01% |
88,206
-31,357
| -26% | -$1.34M |
2013 Q2
50 quarters
|
|
2461
CALL
Molina Healthcare
MOH
$9.91B
| $3.57M | ﹤0.01% |
+20,600
| New | +$3.39M |
2025 Q4
0 quarters
|
|
2462
Stewart Information Services
STC
$1.55B
| $3.57M | ﹤0.01% |
50,822
+4,604
| +10% | +$332K |
2013 Q2
50 quarters
|
|
2463
Worthington Enterprises
WOR
$2.94B
| $3.57M | ﹤0.01% |
69,172
+7,369
| +12% | +$407K |
2013 Q2
50 quarters
|
|
2464
Amylyx Pharmaceuticals
AMLX
$3.48B
| $3.57M | ﹤0.01% |
295,177
-118,935
| -29% | -$1.62M |
2022 Q1
15 quarters
|
|
2465
Arbor Realty Trust
ABR
$647M
| $3.56M | ﹤0.01% |
458,435
-350,313
| -43% | -$3.43M |
2018 Q2
30 quarters
|
|
2466
BellRing Brands
BRBR
$880M
| $3.55M | ﹤0.01% |
132,750
-131,723
| -50% | -$4.09M |
2021 Q4
16 quarters
|
|
|
ARIS
2467
Aris Mining
ARIS
$3.59B
| $3.54M | ﹤0.01% |
218,371
-20,002
| -8% | -$246K |
2023 Q3
9 quarters
|
|
2468
SiriusPoint
SPNT
$2.83B
| $3.54M | ﹤0.01% |
161,653
+13,557
| +9% | +$272K |
2022 Q1
15 quarters
|
|
2469
CALL
Coupang
CPNG
$24.9B
| $3.54M | ﹤0.01% |
+150,000
| New | +$4.27M |
2025 Q4
0 quarters
|
|
2470
Acushnet Holdings
GOLF
$4.8B
| $3.54M | ﹤0.01% |
44,311
+4,750
| +12% | +$386K |
2016 Q4
36 quarters
|
|
2471
PUT
Amgen
AMGN
$217B
| $3.53M | ﹤0.01% |
10,800
-14,700
| -58% | -$4.66M |
2024 Q3
5 quarters
|
|
2472
Diodes
DIOD
$4.67B
| $3.53M | ﹤0.01% |
71,579
+6,928
| +11% | +$351K |
2013 Q2
50 quarters
|
|
2473
Rithm Capital
RITM
$4.86B
| $3.53M | ﹤0.01% |
323,878
+56,537
| +21% | +$625K |
2013 Q2
50 quarters
|
|
|
SVIA
2474
Silvia, Inc. Common Stock
SVIA
$403M
| $3.53M | ﹤0.01% |
1,000,000
+807,600
| +420% | +$6.44M |
2025 Q2
2 quarters
|
|
2475
St. Joe Company
JOE
$3.69B
| $3.53M | ﹤0.01% |
59,388
+4,863
| +9% | +$272K |
2013 Q2
50 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.